These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378 [TBL] [Abstract][Full Text] [Related]
3. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804 [TBL] [Abstract][Full Text] [Related]
4. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study. Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271 [TBL] [Abstract][Full Text] [Related]
5. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Jefic D; Lee JW; Jefic D; Savoy-Moore RT; Rosman HS Chest; 2005 Jul; 128(1):288-95. PubMed ID: 16002948 [TBL] [Abstract][Full Text] [Related]
6. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease]. Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803 [TBL] [Abstract][Full Text] [Related]
7. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931 [TBL] [Abstract][Full Text] [Related]
9. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185 [TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
11. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
12. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030 [TBL] [Abstract][Full Text] [Related]
13. Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). Fradley MG; Larson MG; Cheng S; McCabe E; Coglianese E; Shah RV; Levy D; Vasan RS; Wang TJ Am J Cardiol; 2011 Nov; 108(9):1341-5. PubMed ID: 21864812 [TBL] [Abstract][Full Text] [Related]
14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053 [TBL] [Abstract][Full Text] [Related]
15. NTproBNP: an important biomarker in cardiac diseases. Panagopoulou V; Deftereos S; Kossyvakis C; Raisakis K; Giannopoulos G; Bouras G; Pyrgakis V; Cleman MW Curr Top Med Chem; 2013; 13(2):82-94. PubMed ID: 23470072 [TBL] [Abstract][Full Text] [Related]
16. Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests. Jungbauer CG; Kaess B; Buchner S; Birner C; Lubnow M; Resch M; Debl K; Buesing M; Zerback R; Riegger G; Luchner A Biomark Med; 2012 Dec; 6(6):789-96. PubMed ID: 23227844 [TBL] [Abstract][Full Text] [Related]
18. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859 [TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. St Peter JV; Hartley GG; Murakami MM; Apple FS Clin Chem; 2006 Apr; 52(4):680-5. PubMed ID: 16497939 [TBL] [Abstract][Full Text] [Related]
20. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study. Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]